| Debra F Hobbins, APRN | |
|
915 W Northern Lights Blvd, Anchorage, AK 99503-2408 | |
| (907) 770-6700 | |
| Not Available |
| Full Name | Debra F Hobbins |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 915 W Northern Lights Blvd, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417942517 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 223134-8900 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Debra F Hobbins, APRN 4715 E 112th Ave, Anchorage, AK 99516-1611 Ph: (801) 259-5514 | Debra F Hobbins, APRN 915 W Northern Lights Blvd, Anchorage, AK 99503-2408 Ph: (907) 770-6700 |
News Archive
The New York Times reports: "The nation's drive toward computerized medical records is getting a push from big hospitals, which hope not only to improve patient care but to gain an edge on competitors. And an effort to be announced on Monday by a big New York regional hospital group may be the most ambitious effort of this type yet — a sizable investment intended as a linchpin in the group's $400 million commitment to digitize patient records throughout its system, including 13 hospitals."
In a recent bioRxiv* preprint paper, Professor Miles W. Carroll et al. study an agonist for reducing the SARS-CoV-2's viral load. They show that prophylactic intra-nasal administration of TLR2/6 (toll-like receptor) agonist, INNA-051, reduces viral RNA in the nose and throat, in a ferret model.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levetiracetam Tablets, 1000 mg.
Only a short time after introducing its newly developed and validated tapentadol assay, Dominion Diagnostics (Dominion) is pleased to announce an important enhancement to another clinical laboratory test.
In a study published today in the Journal of the American College of Cardiology of more than 5,000 acute coronary syndromes (ACS) patients, 71.8% were considered malnourished by at least one nutrition screening test, and worsening malnutrition status was associated with higher mortality and major adverse cardiovascular events (MACE), such as another heart attack or stroke.
› Verified 2 days ago
Ms. Mary Kay Mccarty, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3925 Tudor Centre Dr, #100, Anchorage, AK 99508 Phone: 907-561-8301 Fax: 907-561-8170 | |
Mindy Lorin Schloss, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6852 Cutty Sark St, Anchorage, AK 99502 Phone: 907-243-5936 | |
Katherine L Sterner, A.N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4201 Tudor Centre Dr, Suite 320, Anchorage, AK 99508 Phone: 907-729-4955 | |
Sandra Frenier, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3340 Providence Dr, Suite 452, Anchorage, AK 99508 Phone: 907-562-2120 | |
Janet A Bloch, ANP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3851 Piper St, U340, Anchorage, AK 99508 Phone: 907-562-0321 Fax: 907-562-2683 | |
Lois A Rockcastle, ANP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3801 University Lake Dr Ste 205, Anchorage, AK 99508 Phone: 907-563-1600 Fax: 907-563-0100 | |
Mrs. Megan Renee Hathcoat, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1200 Airport Heights Dr Ste 200, Anchorage, AK 99508 Phone: 907-262-4278 |